PharVision Advisers’s Compass Minerals CMP Stock Holding History

PharVision Advisers’s Portfolio CMP Stock Details CMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,003	Closed	-$255K	–	213
2025 Q4	$255K	Buy	+13,003	New	+$241K	0.13%	382

Other funds holding CMP

Koch Inc Wichita, Kansas $1.09B AUM 59.79% 1-Year Est. Return

SCP

SailingStone Capital Partners Houston, Texas $534M AUM 51.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EMCIP

Ewing Morris & Co Investment Partners Toronto, Ontario, Canada $191M AUM 23.88% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

ECM

Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return

ICM

Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return

GCM

Gumshoe Capital Management New York $109M AUM

PharVision Advisers's CMP Position: Q1 2026 in Review

PharVision Advisers sold out of Compass Minerals (CMP) in Q1 2026, closing a stake of 13,003 shares — an estimated $255K sold.

PharVision Advisers first reported a position in CMP in Q4 2025 and held it in 1 quarter. The position peaked at $255K in Q4 2025. 205 funds tracked by Wall St. Rank hold CMP as of Q1 2026.

PharVision Advisers reported no remaining Compass Minerals position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 13,003 Compass Minerals shares in Q1 2026, an estimated $255K.
PharVision Advisers first reported a position in Compass Minerals in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Compass Minerals position peaked at $255K in Q4 2025.
205 funds tracked by Wall St. Rank held Compass Minerals as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.